These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 9076700)

  • 1. Esophageal cancer genetics in South Africa.
    Alaouna M; Hull R; Penny C; Dlamini Z
    Clin Exp Gastroenterol; 2019; 12():157-177. PubMed ID: 31114287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin in Prevention of the Sequence from Reflux Esophagitis to Barrett's Esophagus and Esophageal Adenocarcinoma: Experimental and Clinical Perspectives.
    Majka J; Wierdak M; Brzozowska I; Magierowski M; Szlachcic A; Wojcik D; Kwiecien S; Magierowska K; Zagajewski J; Brzozowski T
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased level of serum prostaglandin-2 in early stage of esophageal squamous cell carcinoma.
    Diakowska D; Markocka-Mączka K; Nienartowicz M; Lewandowski A; Grabowski K
    Arch Med Sci; 2014 Oct; 10(5):956-61. PubMed ID: 25395947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious effects of prostaglandin E2 in reflux oesophagitis.
    Morgan G
    Med Hypotheses; 1996 Jan; 46(1):42-4. PubMed ID: 8746127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
    Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
    Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyclooxygenase-2 non-selective and selective inhibitors on proliferation inhibition and apoptosis induction of esophageal squamous carcinoma cells.
    Li P; Zhang ST; Yu ZL; Wu YD; Liu X; Xu CM; Cho CH
    Dis Esophagus; 2009; 22(1):21-31. PubMed ID: 18564172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
    Tsibouris P; Hendrickse MT; Isaacs PE
    Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleterious effects of prostaglandin E2 in oesophageal carcinogenesis.
    Morgan G
    Med Hypotheses; 1997 Feb; 48(2):177-81. PubMed ID: 9076700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and esophageal squamous cell carcinoma: bedside to bench.
    Li P; Cheng R; Zhang S
    Chin Med J (Engl); 2014; 127(7):1365-9. PubMed ID: 24709195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for esophageal cancer, and possible genetic background].
    Hagymási K; Tulassay Z
    Orv Hetil; 2009 Mar; 150(9):407-13. PubMed ID: 19228569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma.
    Asgari M; White E; Chren MM
    Dermatol Surg; 2004 Oct; 30(10):1335-42. PubMed ID: 15458531
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.